BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6166545)

  • 1. Binding of aggregated human gamma globulin by Raji cells: C1q will enhance only if it is dissociated from the C1 macromolecular complex.
    Manthei U; Strunk RC
    Immunology; 1981 Jun; 43(2):287-92. PubMed ID: 6166545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
    Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
    Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding and activation of the Clr-Cls subunit of the first component of human complement.
    Hughes-Jones NC; Gorick BD
    Mol Immunol; 1982 Sep; 19(9):1105-12. PubMed ID: 6292705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Raji cell radioimmune assay for detecting immune complexes in human sera.
    Theofilopoulos AN; Wilson CB; Dixon FJ
    J Clin Invest; 1976 Jan; 57(1):169-82. PubMed ID: 128562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common epitopes in Clq and collagen type II.
    Heinz HP; Rubin K; Laurell AB; Loos M
    Mol Immunol; 1989 Feb; 26(2):163-9. PubMed ID: 2465489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of circulating immune complexes by chicken anti-human C3 and anti-human C1q microELISA.
    Larsson A; Jonsson L; Sjöquist J
    J Immunol Methods; 1988 Oct; 113(1):93-9. PubMed ID: 3262687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of IgG Fc receptors on spermatozoa and their utilization for the detection of circulating immune complexes in human serum.
    Witkin SS; Shahani SK; Gupta S; Good RA; Day NK
    Clin Exp Immunol; 1980 Sep; 41(3):441-52. PubMed ID: 6160008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clq enhancement of IgG-dependent eosinophil-mediated killing of schistosomula in vitro.
    Hamada A; Greene BM
    J Immunol; 1987 Feb; 138(4):1240-5. PubMed ID: 3492545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on circulating immune complexes of the liver disease. 3. Conditions for Clq binding assay and low molecular weight Clq reactants.
    Arima T; Narumoto J; Shimomura H; Suwaki K; Kunishi K; Yasuhara T; Nagashima H
    Gastroenterol Jpn; 1980; 15(1):20-6. PubMed ID: 6153627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of circulating immune complexes in human sera by enzyme immunoassay.
    Cheung K; O'Kane D; Robinson MF
    Aust J Exp Biol Med Sci; 1982 Dec; 60(6):593-605. PubMed ID: 6820632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the "arms" of C1q.
    Hoekzema R; Martens M; Brouwer MC; Hack CE
    Mol Immunol; 1988 May; 25(5):485-94. PubMed ID: 3261834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of C1q subcomponent with immunoglobulin M.
    Kimak E; Tomaszewski JJ
    Acta Biochim Pol; 1986; 33(3):179-85. PubMed ID: 2433858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of C3-IgG complexes in serum by aggregated IgG and by non-immunoglobulin activators of complement.
    van Dam AP; Hack CE
    Immunology; 1987 Jun; 61(2):105-10. PubMed ID: 3596635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a Cordia-IC enzyme-linked immunosorbent assay kit for the detection of circulating immune complexes.
    Landoy Z; West TE; Vladutiu AO; Fitzpatrick JE
    J Clin Microbiol; 1985 Aug; 22(2):279-82. PubMed ID: 3897269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and plasma fibronectin binds to complement reacted immune complexes primarily via Clq.
    Baatrup G; Svehag SE
    Scand J Immunol; 1986 Nov; 24(5):583-90. PubMed ID: 3097811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody to a cryptic, solid phase C1Q antigen in membranoproliferative nephritis.
    Strife CF; Leahy AE; West CD
    Kidney Int; 1989 Mar; 35(3):836-42. PubMed ID: 2785226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
    Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
    Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus.
    Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
    Clin Exp Immunol; 1987 Jul; 69(1):98-106. PubMed ID: 3498589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.